Structural basis for the inhibition of the SARS-CoV-2 main protease by the anti-HCV drug narlaprevir.

ABSTRACT:

SUBMITTER: Bai Y 

PROVIDER: S-EPMC7860160 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature